Maximilian Englert

All Publications

• Platelet-specific SLFN14 deletion causes macrothrombocytopenia and platelet dysfunction through dysregulated megakaryocyte and platelet gene expression JOURNAL OF CLINICAL INVESTIGATION Stapley, R. J., Sawkulycz, X., Araujo, G. H. M., Englert, M., Garcia-Quintanilla, L., Smith, S. R. M., Ahmed, A., Haining, E. J., Kaur, N., Bacon, A., Pisarev, A., Poulter, N. S., Kavanagh, D., Thomas, S. G., Montague, S. J., Rayes, J., Nagy, Z., Morgan, N. 2025; 135 (20)

  Abstract

  Schlafen 14-related (SLFN14-related) thrombocytopenia is a rare bleeding disorder caused by SLFN14 mutations altering hemostasis in patients with platelet dysfunction. SLFN proteins are highly conserved in mammals where SLFN14 is specifically expressed in megakaryocyte (MK) and erythroblast lineages. The role of SLFN14 in megakaryopoiesis and platelet function has not been elucidated. Therefore, we generated a murine model with a platelet- and MK-specific SLFN14 deletion using platelet factor 4 (PF4) Cre-mediated deletion of exons 2 and 3 in Slfn14 (Slfn14 PF4-Cre) to decipher the molecular mechanisms driving the bleeding phenotype. Slfn14 PF4-Cre+ platelets displayed reduced platelet signaling to thrombin, reduced thrombin formation, increased bleeding tendency, and delayed thrombus formation as assessed by intravital imaging. Moreover, fewer in situ bone marrow MKs were present compared with controls. RNA-Seq and Gene Ontology analysis of MKs and platelets from Slfn14 PF4-Cre homozygous mice revealed altered pathways of ubiquitination, adenosine triphosphate activity, and cytoskeleton and molecular function. In summary, we investigated how SLFN14 deletion in MKs and platelets leads to platelet dysfunction and alters their transcriptome, explaining the platelet dysfunction and bleeding in humans and mice with SLFN14 mutations.

  View details for DOI 10.1172/JCI189100

  View details for Web of Science ID 001613739800004

  View details for PubMedID 40794453

  View details for PubMedCentralID PMC12520693